4
Changes in Ownership
CLOROX CO /DE/ Filed Acc 0001225208-19-009058
SVP - Chief Innovation Officer sold 20,399 shares at an average $157.61 ($3,215,035)
- SVP - Chief Innovation Officer acquired 21,127 shares (option exercise)
- SVP - Chief Innovation Officer disposed of 6,374 shares (other)
- SVP - Chief Innovation Officer acquired 6,374 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GARNER DENISE SVP - Chief Innovation Officer | 2019-05-03 | Other disposition | −6,374 | 4,896 | D | ||
| GARNER DENISE SVP - Chief Innovation Officer | 2019-06-06 | Option exercise | +9,720 | $103.89 | $1,009,811 | 14,616 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2019-06-06 | Sale | −9,373 | $156.12 | $1,463,318 | 5,243 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2019-06-07 | Option exercise | +11,407 | $111.60 | $1,273,021 | 16,650 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2019-06-07 | Sale | −3,040 | $157.88 | $479,965 | 13,610 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2019-06-07 | Sale | −7,986 | $159.25 | $1,271,752 | 5,624 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2019-05-03 | Other acquisition | +6,374 | 6,374 | I | ||
| Derivatives | |||||||
| GARNER DENISE SVP - Chief Innovation Officer | 2019-06-06 | Option exercise · Stock Option (Right to Buy) | −9,720 | 0 | D | ||
| GARNER DENISE SVP - Chief Innovation Officer | 2019-06-07 | Option exercise · Stock Option (Right to Buy) | −11,407 | 3,803 | D | ||
| Open-market sales · 20,399 sh · avg $157.61 · $3,215,035 | |||||||
Loading xslF345X03/doc4.xml…